Discovery of tumor markers for gastric cancer by proteomics

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wu, Jeng Yih ^a,b,c   Cheng, Chun Chia ^d   Wang, Jaw Yuan ^b   Wu, Deng Chyang ^b,c,e   Hsieh, Jan Sing ^b   Lee, Shui Cheng ^b   Wang, Wen Ming ^a,b,c  

^a KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^e KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; GASTROKINE 1; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE TRANSFERASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION IMAGING MASS SPECTROMETRY; MIDDLE AGED; PROTEIN EXPRESSION; PROTEOMICS; STOMACH CANCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84896778540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084158     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
2. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, et al. (2008) Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23: 351-365. (Pubitemid 351342074)
3. Torpy JM, Lynm C, Glass RM (2010) JAMA patient page. Stomach cancer. JAMA 303: 1771.
4. Ferlay J SH, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
5. Sant M, Capocaccia R, Verdecchia A, Esteve J, Gatta G, et al. (1998) Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer 77: 679-683. (Pubitemid 28341382)
6. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, et al. (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102: 1584-1598.
7. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, et al. (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98: 735-739. (Pubitemid 36576295)
8. Miki K (2006) Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 9: 245-253. (Pubitemid 44846546)
9. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, et al. (2011) Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One 6: e26957.
10. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y (2006) Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 12: 4873-4874. (Pubitemid 44323214)
11. Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122: 1609-1619. (Pubitemid 34533556)
12. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421-430. (Pubitemid 32844200)
13. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, et al. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327. (Pubitemid 46631379)
14. Tsutsumi M, Sugisaki T, Makino T, Miyagi N, Nakatani K, et al. (1987) Oncofetal expression of glutathione S-transferase placental form in human stomach carcinomas. Jpn J Cancer Res 78: 631-633. (Pubitemid 17124006)
15. Niitsu Y, Takahashi Y, Saito T, Hirata Y, Arisato N, et al. (1989) Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer 63: 317-323. (Pubitemid 19035025)
16. Monden N, Abe S, Sutoh I, Hishikawa Y, Kinugasa S, et al. (1997) Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology 54: 391-399. (Pubitemid 27321118)
17. Langer R, Feith M, Siewert JR, Wester HJ, Hoefler H (2008) Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 8: 70.
18. Takahashi H, Wang JP, Zheng HC, Masuda S, Takano Y (2011) Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis. Histol Histopathol 26: 663-671.
19. Liu H, Miller E, van de Water B, Stevens JL (1998) Endoplasmic reticulum stress proteins block oxidant-induced Ca2+ increases and cell death. J Biol Chem 273: 12858-12862. (Pubitemid 28246843)
20. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS (1994) The glucoseregulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr 4: 1-18.
21. Zhang J, Jiang Y, Jia Z, Li Q, Gong W, et al. (2006) Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 23: 401-410. (Pubitemid 46197122)
22. Tall AR (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263: 256-273. (Pubitemid 351207349)
23. Berbee JF, Havekes LM, Rensen PC (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11: 97-103. (Pubitemid 40711485)
24. Bernacka K, Kuryliszyn-Moskal A, Sierakowski S (1988) The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis. Cancer 62: 1188-1193.
25. Pott GB, Chan ED, Dinarello CA, Shapiro L (2009) Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 85: 886-895.
26. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402. (Pubitemid 30164342)
27. Lacy ER, Morris GP, Cohen MM (1993) Rapid repair of the surface epithelium in human gastric mucosa after acute superficial injury. J Clin Gastroenterol 17 Suppl 1: S125-135. (Pubitemid 23320760)
28. Podolsky DK (1997) Healing the epithelium: solving the problem from two sides. J Gastroenterol 32: 122-126. (Pubitemid 27075894)
29. Rippa E, La Monica G, Allocca R, Romano MF, De Palma M, et al. (2011) Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol 226: 2571-2578.
30. Bai Z, Ye Y, Liang B, Xu F, Zhang H, et al. (2011) Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol 38: 375-383.